Established in 2021, the Regenerative Medicine Acceleration Foundation (RMAF) is the designated Advanced Regenerative Medicine Support Institution under the Act on the Safety of and Support for Advanced Regenerative Medicine and Advanced Biological Products. RMAF promotes patients' access to innovative medical technologies by driving policy development, advancing clinical research, fostering experts, and supporting the designation of implementation institutions, therapeutics systems, and international cooperation. Serving as a central hub of the regenerative medicine ecosystem, RMAF bridges the gap between scientific discovery and patient care. RMAF pioneers regenerative medicine to overcome incurable diseases and improve global health by collaborating with diverse stakeholders.